Correlation Between Liontrust Asset and Ondine Biomedical

Can any of the company-specific risk be diversified away by investing in both Liontrust Asset and Ondine Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Liontrust Asset and Ondine Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Liontrust Asset Management and Ondine Biomedical, you can compare the effects of market volatilities on Liontrust Asset and Ondine Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Liontrust Asset with a short position of Ondine Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Liontrust Asset and Ondine Biomedical.

Diversification Opportunities for Liontrust Asset and Ondine Biomedical

-0.63

Correlation Coefficient

Liontrust Asset  Ondine Biomedical

Excellent diversification

The 3 months correlation between Liontrust and Ondine is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Liontrust Asset Management and Ondine Biomedical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ondine Biomedical and Liontrust Asset is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Liontrust Asset Management are associated (or correlated) with Ondine Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ondine Biomedical has no effect on the direction of Liontrust Asset i.e., Liontrust Asset and Ondine Biomedical go up and down completely randomly.

Pair Corralation between Liontrust Asset and Ondine Biomedical

Assuming the 90 days trading horizon Liontrust Asset Management is expected to under-perform the Ondine Biomedical. But the stock apears to be less risky and, when comparing its historical volatility, Liontrust Asset Management is 2.49 times less risky than Ondine Biomedical. The stock trades about -0.1 of its potential returns per unit of risk. The Ondine Biomedical is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  563.00  in Ondine Biomedical on September 23, 2024 and sell it today you would earn a total of  287.00  from holding Ondine Biomedical or generate 50.98% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Liontrust Asset Management  vs.  Ondine Biomedical

Liontrust Asset Mana

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Liontrust Asset Management has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Ondine Biomedical

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Ondine Biomedical are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady technical and fundamental indicators, Ondine Biomedical exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Liontrust Asset and Ondine Biomedical

The main advantage of trading using opposite Liontrust Asset and Ondine Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Liontrust Asset position performs unexpectedly, Ondine Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ondine Biomedical will offset losses from the drop in Ondine Biomedical's long position.

The idea behind Liontrust Asset Management and Ondine Biomedical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.